| Title | Author(s) | Year | View Count |
 | Enteropathy-associated T-cell lymphoma: Clinical and histological findings from the international peripheral T-Cell lymphoma project | Delabie, J; Holte, H; Vose, JM; Ullrich, F; Jaffe, ES; Savage, KJ; Connors, JM; Rimsza, L; Harris, NL; MüllerHermelink, K; Rüdiger, T; Coiffier, B; Gascoyne, RD; Berger, F; Tobinai, K; Au, WY; Liang, R; Montserrat, E; Hochberg, EP; Pileri, S; Federico, M; Nathwani, B; Armitage, JO; Weisenburger, DD | 2011 | 97 |
| Erratum: Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro (Leukemia (2011) 25 (348-358) DOI:10.1038/leu.2010.255) | Iqbal, J; Weisenburger, DD; Chowdhury, A; Tsai, MY; Srivastava, G; Greiner, TC; Kucuk, C; Deffenbacher, K; Vose, J; Smith, L; Au, WY; Nakamura, S; Seto, M; Delabie, J; Berger, F; Loong, F; Ko, YH; Sng, I; Liu, X; Loughran, TP; Armitage, J; Chan, WC | 2011 | 64 |
| Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro | Iqbal, J; Weisenburger, DD; Chowdhury, A; Tsai, MY; Srivastava, G; Greiner, TC; Kucuk, C; Deffenbacher, K; Vose, J; Smith, L; Au, WY; Nakamura, S; Seto, M; Delabie, J; Berger, F; Loong, F; Ko, YH; Sng, I; Liu, X; Loughran, TP; Armitage, J; Chan, WC | 2011 | 138 |
| Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: A case report | Naushad, H; Choi, WWL; Page, CJ; Sanger, WG; Weisenburger, DD; Aoun, P | 2009 | 223 |
 | NK-cell lymphoma shares strikingly similar molecular features with a distinct set of gamma delta T-cell lymphoma and identification of aurora kinase A inhibitor as a novel therapeutic agent | Iqbal, J; Weisenburger, DD; Chowdhury, A; Srivastava, G; Greiner, TC; Deffenbacher, KE; Kucuk, C; Vose, JM; Au, WY; Nakamura, S; Seto, M; Delabie, J; Berger, F; Loong, F; Ko, YH; Sng, I; Liu, X; Loughran, TP; Tsai, M; Armitage, JO; Chan, WC | 2009 | 113 |
| Reply to Suzuki et al: Prognosis of stage I/II non-nasal extranodal NK/T cell lymphoma for the International Peripheral T-cell Lymphoma Project | Au, WY; Weisenburger, DD; Liang, RHS | 2009 | 141 |
| Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: A study of 136 cases from the International Peripheral T-Cell Lymphoma Project | Au, WY; Weisenburger, DD; Intragumtornchai, T; Nakamura, S; Kim, WS; Sng, I; Vose, J; Armitage, JO; Liang, R | 2009 | 236 |
| Neither Cell Of Origin Algorithms Or LMO2 Expression Predicts Survival In DLBCL Treated With Autologous Hematopoietic Stem Cell (HSC) Transplantation | Gu, K; Fu, K; Chan, WC; Greiner, TC; Aoun, P; Smith, LM; Liu, Z; Meyer, PN; Choi, WL; Bociek, G; Vose, JM; Weisenburger, DD | 2009 | 127 |
| LMO2 Expression And The Hans Algorithm In Predicting Germinal Center Phenotype And Survival In Diffuse Large B-cell Lymphoma Treated With Rituximab | Meyer, PN; Weisenburger, DD; Choi, WL; Smith, LM; Greiner, TC; Aoun, P; Delabie, J; Braziel, RM; Vose, JM; Lenz, G; Staudt, LM; Chan, WC; Fu, K | 2009 | 109 |
| A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy | Choi, WWL; Weisenburger, DD; Greiner, TC; Piris, MA; Banham, AH; Delabie, J; Braziel, RM; Geng, H; Iqbal, J; Lenz, G; Vose, JM; Hans, CP; Fu, K; Smith, LM; Li, M; Liu, Z; Gascoyne, RD; Rosenwald, A; Ott, G; Rimsza, LM; Campo, E; Jaffe, ES; Jaye, DL; Staudt, LM; Chan, WC | 2009 | 142 |
| T-Cell project: An international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma | Projeto de célula-T: Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo | Federico, M; Bellei, M; Pesce, E; Zucca, E; Pileri, S; Montoto, S; Weisenburger, DD; Ruediger, T; Ko, YH; Liang, R; Zinzani, PL; Connors, JM; Foss, FM; Horwitz, SM; Polliack, A; Vose, JM | 2009 | 72 |
| Response: Prognosis of stage I/II nonnasal extranodal NK/T cell lymphoma | Au, WY; Weisenburger, DD; Liang, R | 2009 | 29 |
| Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma | Fu, K; Weisenburger, DD; Choi, WWL; Perry, KD; Smith, LM; Shi, X; Hans, CP; Greiner, TC; Bierman, PJ; Bociek, RG; Armitage, JO; Chan, WC; Vose, JM | 2008 | 201 |
 | Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients | Anderson, JR; Armitage, JO; Berger, F; Cavalli, F; Chan, WC; Close, J; Coiffier, B; Connors, J; Diebold, J; Gascoyne, R; Harris, N; Hiddemann, W; Ho, F; Jacobs, P; Liang, R; Lister, TA; MacLennan, KA; Muller-Hermelink, HK; Nathwani, BN; Norton, A; Ott, G; Pedrinis, E; Roy, P; Schauer, A; Weisenburger, DD | 1997 | 181 |
| A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project | Anderson, J; Armitage, JO; Berger, F; Cavalli, F; Chan, WC; Close, J; Coiffier, B; Connors, J; Diebold, J; Gascoyne, R; Harris, N; Hiddemann, W; Ho, FCS; Jacobs, P; Liang, RHS; Lister, TA; MacLennan, K; Muller-Hermelink, HK; Nathwani, BN; Norton, A; Ott, G; Pedrinis, E; Roy, P; Schauer, A; Weisenburger, DD | 1997 | 125 |
|
